Literature DB >> 31343339

The epidemiology of amyloidosis in Australia.

Brendan Wisniowski1, Donald McLeod2, Rebecca Adams3,4,5, Yasmin Harvey6, Jane Armes1, David Papadimos6, Ian Brown7, Lloyd McGuire8, Peter Mollee5,9.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31343339     DOI： 10.1080/13506129.2019.1582481

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  3 in total

1.  Risks of Ventricular Tachyarrhythmia and Mortality in Patients with Amyloidosis - A Long-Term Cohort Study.

Authors:  Yun-Yu Chen; Ming-Jen Kuo; Fa-Po Chung; Yenn-Jiang Lin; Kuo-Liong Chien; Yu-Cheng Hsieh; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Tze-Fan Chao; Jo-Nan Liao; Ting-Yung Chang; Chin-Yu Lin; Ling Kuo; Ta-Chuan Tuan; Cheng-I Wu; Chih-Min Liu; Shin-Huei Liu; Cheng-Hung Li; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2022-07       Impact factor: 1.800

Review 2.  Cardiac Amyloidosis.

Authors:  Morie A Gertz
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

3.  Incidence, Cause of Death, and Survival of Amyloidosis in Korea: A Retrospective Population-Based Study.

Authors:  Shin Yi Jang; Darae Kim; Jin-Oh Choi; Eun-Seok Jeon
Journal:  Int J Heart Fail       Date:  2021-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.